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BACKGROUND
Cancer is predominantly a disease of older people and accounts for the greatest burden of disease in 
Australia. Cancer incidence is expected to increase, given that the population aged 65 years and over is 
estimated to reach one quarter of the population  by the year 20561. In 2011, the Princess Alexandra Hospital 
treated 544 patients aged 65 years and over with chemotherapy. An estimated 39% of all chemotherapy 
patients each year are in this age bracket.
The Vulnerable Elder’s Survey-13 (VES-13) 
is increasingly used to screen for older 
patients who can proceed to intensive 
chemotherapy without further comprehensive 
assessment. An observational study was 
conducted, of patients over 65 years of age, 
to evaluate the effectiveness of current 
geriatric screening and comprehensive 
assessment processes. The following results 
are from analyses conducted to compare 
the VES-13 screening component, with 
blinded ratings of the patient’s treating 
oncologist. 
STUDY DESIGN
All participants were screened by their treating oncologist. After consent, they were assessed for 
‘fitness’ or ‘vulnerability’ to chemotherapy by a geriatric nurse using the Vulnerable Elders Survey-13 
(VES-13) screening tool. Blinded to this screening result, oncologists also assessed patients for fitness for 
chemotherapy (rated as fit, vulnerable or frail) based on their clinical judgement. The study was granted 
ethical approval by both the PAH and QUT Human Research Ethics Committees. 
INSTRUMENTS
ANALYSIS
RESULTS
RESULTS
ONCOLOGISTS’ RATINGS
One hundred and seventy-five participants were recruited into the study (109 men and 66 women). They 
had a mean age of  72.02 years (SD = 5.17).
Kappa tests, using IBM SPSS Version 20.0, determined the degree of agreement between oncologist and 
VES-13 ratings of patient fitness. Logistic regression analysis determined those factors influencing a 
prediction of fitness as determined by the VES-13 and the oncologist. 
IMPLICATIONS FOR PRACTICE
VES-13 screening instrument
Provides rapid appraisal of functional ability, self-reported health status and weighted 
chronological age.
Stratifies participants into  two groups: fit to progress to chemotherapy or vulnerable.
Determines who may require a comprehensive assessment.
Cumulative Illness Rating Scale -
Geriatrics (CIRS-G)
Number and severity of pre-existing illnesses
Malnutrition Screening Tool (MST) Malnutrition risk
Standardised Mini Mental State 
Examination (SMMSE)
Assesses cognitive function
Geriatric Depression Scale – 15 
(GDS)
Age-specific depression
Modified Barthel Index (MBI) Assesses functional abilities using the basic activities of daily living (e.g. showering, walking, toilet)
The Lawton Instrumental Activities 
of Daily Living (IADL)
Assesses complex functional ability (e.g. shopping, cooking, finances)
Full medical and social history Social support and relevant medical history
Assessed for Eligibility (n =230)
Excluded (n = 52)
    Not meeting eligibility criteria (n = 12)
    Declined to participate  (n = 40)
Began study (n =178)
Withdrew before completion (n = 3)
Analysed (n = 175)
Excluded from analysis (n = 0)
Enrolment
Assessment
Analysis
The Kappa coefficient of agreement between the VES-13 
and oncologists’ ratings of fitness was 0.41 
(p < 0.001) (“moderate”). VES-13 and oncologists’ 
assessments agreed in 71% of ratings (see Figure 4).
Sensitivity = 83.3%   
Specificity = 57%
Positive predictive value = 69%
Negative predictive value = 75%
Participant eligibility criteria
• 65 years or older
• Diagnosis of new primary or
   recurrence of a solid tumour
Oncologist Assessment
Fit
Vulnerable
Frail
VES-13
(Geriatric Nurse)
Fit
Vulnerable
Other Assessments
(Geriatric Nurse)
Table 1. Model of significant predictors of VES-13 ratings for 
vulnerability to chemotherapy (n=172)
          Adjusted OR     95% CI    Sig
Depression             1.42   (1.18, 1.71)  <.001
Functional independence         0.82   (0.74, 0.92)  <.001
(Barthel Index)
Functional independence         0.44   (0.30, 0.65)  <.001
(IADL)
IADL = Instrumental Activities of Daily Living
 
Table 2. Model of significant predictors of oncologists’ ratings for 
vulnerability to chemotherapy (n=166)
          Adjusted OR     95% CI    Sig
Age                 1.15   (1.07, 1.23)  <.001
Depression              1.23   (1.06, 1.43)  .006
Functional independence          0.91   (.085, 0.985)  .01
(Barthel Index) 
Our data indicate moderate agreement between VES-13 and clinician assessments of patients’ fitness 
for chemotherapy. Current ‘one-step’ screening processes to determine fitness have limits. Nonetheless, 
screening tools do have the potential for modification and enhanced predictive properties in cancer care 
by adding relevant items, thus enabling fit patients to be immediately referred for chemotherapy. 
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